A ruthenium(ii) based photosensitizer and transferrin complexes enhance photo-physical properties, cell uptake, and photodynamic therapy safety and efficacy-Reference-Cited by-同舟云学术

A ruthenium(ii) based photosensitizer and transferrin complexes enhance photo-physical properties, cell uptake, and photodynamic therapy safety and efficacy

Published:2016 Issue:4 Volume:15 Page:481-495
ISSN:1474-905X
Container-title:Photochemical & Photobiological Sciences
language:en
Short-container-title:Photochem. Photobiol. Sci.

Author:

Kaspler Pavel¹²³,Lazic Savo¹²³,Forward Sarah⁴⁵⁶²³,Arenas Yaxal¹²³,Mandel Arkady¹²³,Lilge Lothar⁴⁵⁶²³

Affiliation:

1. Theralase Inc.

2. Toronto

3. Canada

4. University Health Network

5. Princess Margaret Cancer Research Tower and University of Toronto

6. Department of Medical Biophysics

Abstract

Mixing the novel Ru²⁺complex TLD1433 with transferrin prior to administration generates a photosensitizing drug with reduced dark toxicity and improved photophysical properties including NIR activation.

Publisher

Springer Science and Business Media LLC

Subject

Physical and Theoretical Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2016/PP/C5PP00450K

Reference78 articles.

1. R. Bonnett , Chemical aspects of photodynamic therapy, Gordon and Breach Science Publishers, Amsterdam, The Netherlands, 2000

2. The role of porphyrin chemistry in tumor imaging and photodynamic therapy

3. Photodynamic therapy for cancer

4. Photodynamic therapy with endogenous protoporphyrin

5. Studies of a vascular-acting photosensitizer, Pd-bacteriopheophorbide (Tookad), in normal canine prostate and spontaneous canine prostate cancer

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilizing dual-responsive iridium(III) complex for hepatocellular carcinoma: Integrating photoacoustic imaging with chemotherapy and photodynamic therapy;Chinese Chemical Letters;2024-09

2. Nanomolar concentrations of the photodynamic compound TLD-1433 effectively inactivate numerous human pathogenic viruses;Heliyon;2024-06

3. Ruthenium-Cathepsin Inhibitor Conjugates for Green Light-Activated Photodynamic Therapy and Photochemotherapy;Inorganic Chemistry;2024-04-15

4. Cellular Uptake and Phototoxicity Optimization of Arene Ruthenium Porphyrin Derivatives;Inorganics;2024-03-12

5. Tracking the cellular uptake and phototoxicity of Ru(ii)-polypyridyl-1,8-naphthalimide Tröger's base conjugates;RSC Chemical Biology;2024